T2D.com Tirzepatide Review: Cost, a Diabetes-Focused Integrated Service & Honest Verdict (2026)

T2D.com: built specifically for type 2 diabetic and pre-diabetic patients, offering a fully integrated service — prescriber, pharmacy, and temperature-controlled delivery handled in one flow, though pricing isn't published anywhere on the public site. Every fact here comes from the company's own published program.

What T2D.com is

T2D.com is a telehealth service, built specifically for type 2 diabetic and pre-diabetic patients, offering compounded semaglutide and tirzepatide as an integrated service — prescriber, pharmacy, and delivery in one flow, with temperature-controlled home delivery via UPS or FedEx and ongoing prescriber monitoring. It serves 1 state.

What T2D.com costs

No pricing is published on the public website — you must register to see costs. The ranking's own research places tirzepatide around $999/month for the starting dose, a notably high figure worth confirming directly before assuming it applies.

The brand-vs-compounded question

T2D.com dispenses compounded semaglutide and tirzepatide only — no brand-name Ozempic, Wegovy, or Mounjaro option. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

T2D.com's real strengths is a genuinely focused type 2 diabetes and pre-diabetes model, a fully integrated prescriber-pharmacy-delivery flow, temperature-controlled shipping, and ongoing prescriber monitoring included. The trade-offs: no pricing is published on the public site — you must register to see costs, no states list is published, it's a newer brand with limited independent reviews, and it's compounded only. As with any GLP-1 program, and especially one that gates pricing behind registration, get your actual quoted price before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

T2D.com's genuine focus on type 2 diabetes and pre-diabetes, plus its fully integrated care flow, are real positives, but the gated pricing and single-state footprint are significant limits. For a provider with fully public pricing and broader state coverage, compare it against StackMD or Ondra Health. See our best tirzepatide providers ranking for the full field.